Similarity of insulin-dependent diabetics' and non-insulin-dependent diabetics' levels of β-hCG and unconjugated estriol with controls: No need to adjust as with alpha-fetoprotein

Journal of the Society for Gynecologic Investigation

Volumn 3, Issue 1, 1996, Pages 20-22

  Evans, Mark I ^a   O'Brien, Joseph E ^b   Dvorin, Elena ^b   Krivchenia, Eric L ^b   Drugan, Arie ^b   Hume Jr , Roderick F ^b   Johnson, Mark P ^b  

^a HUTZEL HOSPITAL   (United States)

^b NONE

Author keywords

diabetes; Insulin; multiple marker biochemical screening; screening programs

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CONJUGATED ESTROGEN; ESTRIOL;

ARTICLE; CONTROLLED STUDY; ESTRIOL BLOOD LEVEL; FEMALE; HORMONE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ALPHA-FETOPROTEINS; ANEUPLOIDY; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ESTRIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY IN DIABETICS; REFERENCE VALUES;

EID: 0030048188     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/1071-5576(95)00043-7     Document Type: Article

References (10)

1. Wald NJ, Cuckle HS, Boreham J, Stirrat GM, Turnbull AC. Maternal serum alpha-fetoprotein and diabetes mellitus. Br J Obstet Gynaecol 1979;86:101-5.
2. Baumgarten A, Robinson S. Prospective study of an inverse relationship between maternal glycosylated hemoglobin and serum alpha-fetoprotein concentrations in pregnant women with diabetes. Am J Obstet Gynecol 1988;159:77.
3. Evans MI, Dvorin E, O'Brien JE, Moody ML, Drugan A. Alpha-fetoprotein and biochemical screening. In: Evans MI, ed. Reproductive risks and prenatal diagnosis. Norwalk, Connecticut: Appleton & Lange, 1992:223-36.
4. Evans MI, Chik L, O'Brien JE, et al. MOMs and DADs: improved specificity and cost effectiveness of biochemical screening for aneuploidy with DADs. Am J Obstet Gynecol 1995;172: 1138-47.
5. Evans MI, Chik L, O'Brien JE, et al. Logistic regression generated probability estimates for trisomy 21 outcomes from serum AFP and β-hCG: Simplification with increased specificity. J Mat Fet Med (in press).
6. Wald N, Cuckle H, Boreham J, Terzian E, Redman C. The effect of maternal weight on maternal serum alpha-fetoprotein levels. Br J Obstet Gynaecol 1981;88:1094-6.
7. Drugan A, Dvorin E, Johnson MP, Uhlmann WR, Evans MI. The inadequacy of the current correction for maternal weight in maternal serum alpha-fetoprotein interpretation. Obstet Gynecol 1989;74:698.
8. Evans MI, O'Brien JE, Dvorin E, Johnson MP. Biochemical screening. Cur Opin Obstet Gynecol 1994;6(5):453-8.
9. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
10. Canick JA, Panizza DS, Palomaki GE. Prenatal screening for Down syndrome using AFP, uE3, and hCG: Effect of maternal race, insulin-dependent diabetes and twin pregnancy. Am J Hum Genet 1990;47:A270.